在TET2功能丧失的小鼠中促进克隆造血
Shweta Singh1, Kristbjorn O Gudmundsson1,2, Tanmoy Sarkar1
1Mouse Cancer Genetics Program, Center For Cancer Research, National Cancer Insitute-Frederick, NIH, Frederick, MD 21702, USA.
Science advances
|August 29, 2025
概括
降低血造干细胞 (HSPC) 中的DNA结合1 (ID1) 表达的抑制剂可以降低克隆血造 (CH). 这种方法可以通过向ID1来延缓血液形成恶性瘤的发病.
科学领域:
- 血液学
- 分子生物学
- 癌症研究
背景情况:
- 造血性恶性瘤是由造血干细胞和前代细胞 (HSPC) 的遗传突变引起的.
- 克隆造血 (CH) 是具有突变的HSPC扩张,有助于成熟的血液细胞.
- 抑制DNA结合1 (ID1) 调节HSPC的增殖和分化,并在炎症期间诱导其表达.
研究的目的:
- 研究ID1在CH的发展中的作用.
- 确定减少ID1表达是否可以减轻CH并延迟疾病发作.
- 探索ID1切除对HSPC行为的机械效应.
主要方法:
- 在缺乏Tet2的HSPC中进行ID1的基因切除 (Tet2-/-;Id1-/-).
- 分析HSPC扩张,CH,外骨髓造血,骨髓曲和遗传不稳定性.
- 在突变的HSPC中评估p16表达,衰老,亡和增殖.
主要成果:
- 在Tet2- / - HSPC中对ID1的基因切除显著降低了HSPC扩张和CH.
- 缺少ID1还减少了骨髓外造血,骨髓曲和遗传不稳定性.
- 在机理上,ID1消去增加了p16的表达,衰老和亡,同时降低了HSPC的增殖.
结论:
- ID1在促进HSPC扩张和CH中发挥着关键作用.
- 降低ID1表达是一种潜在的治疗策略,可以对抗CH并延缓造血性恶性瘤.
- 针对ID1可能提供一种新的方法来管理由克隆造血驱动的疾病.
更多相关视频
10:33Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
8.3K
09:32Clonal Analysis of Embryonic Hematopoietic Stem Cell Precursors Using Single Cell Index Sorting Combined with Endothelial Cell Niche Co-culture
Published on: May 8, 2018
8.7K
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Hematopoiesis
5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K
